Picture of Bio Path Holdings logo

BPTH — Bio Path Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Bio Path Holdings Inc reports results for the quarter ended in June - Earnings Summary

* Bio Path Holdings Inc  BPTH.OQ  reported a quarterly
adjusted
loss of 42 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 49 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Bio Path Holdings Inc's reported EPS for the quarter was a
loss
of 42 cents​.
    * The mean earnings estimate of analysts had risen by
about 1% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Bio Path Holdings Inc shares had risen by 6.7% this
quarter and
gained 9.5% so far this year.
    * The company reported a quarterly loss of $3.01 million.
    * Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 16
at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.49          -0.42          Beat
 Mar. 31 2022      -0.45          -0.47          Missed
 Dec. 31 2021      -0.32          -0.59          Missed
 Sep. 30 2021      -0.33          -0.29          Beat

Recent news on Bio Path Holdings

See all news